Business

Dominari Holdings Provides Update on Share Repurchase Program

NEW YORK, March 21, 2023 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the "Company") today provided an update on the $2 million share

articleDominari Holdings Inc.March 21, 20235/company/dominari-holdings-inc/news/dominari-holdings-provides-update-on-share-repurchase-program
Dominari Holdings Provides Update on Share Repurchase Program

About this update from Dominari Holdings Inc.

[{"type":"text","content":"NEW YORK, March 21, 2023 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) (\"Dominari\" or the \"Company\") today provided an update on the $2 million share repurchase program (the \"Share Repurchase Program\") authorized by the Company's Board of Directors on December 5, 2022.\n\n \n \n \n \n \n \n\n \nThe Company reported that on March 20, 2023, the Company purchased 4,900 shares of common stock at $3.3759 per share.\nAdditional shares may be repurchased from time to time in open market transactions, or other means in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and Rule 10b -18 of the Exchange Act. The timing, number of shares repurchased, and prices paid for the stock under this program will depend on general business and market conditions as well as corporate and regulatory limitations, including blackout period restrictions.\nAbout Dominari Holdings Inc. \nDominari Holdings Inc. (f/k/a Aikido Pharma Inc.) until recently was focused primarily on the development of a diverse portfolio of small-molecule anticancer and antiviral therapeutics and related patent technology. In September 2022, the Company agreed to acquire a registered broker-dealer and transition its primary business operations to fintech and financial services. Upon the final closing of this acquisition, the Company's fintech and financial services business will be operated through its subsidiary, Dominari Financial Inc. The Company continues to develop its therapeutics and related patent technology, as well as other ventures, through its subsidiary, Aikido Labs, LLC. \nForward-Looking Statements \nCertain statements in this press release constitute \"forward-looking statements\" within the meaning of the federal securities laws. Words such as \"may,\" \"might,\" \"will,\" \"should,\" \"believe,\" \"expect,\" \"anticipate,\" \"estimate,\" \"continue,\" \"predict,\" \"forecast,\" \"project,\" \"plan,\" \"intend\" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based up...

More updates from Dominari Holdings Inc.